Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stem cell therapy in acute myocardial infarction].

Bodo E Strauer1, Michael Brehm, Tobias Zeus

  • 1Klinik ftir Kardiologie, Pneumologie und Angiologie, Universität Düsseldorf. strauer@med.uni-duesseldorf.de

Medizinische Klinik (Munich, Germany : 1983)
|March 3, 2004
PubMed
Summary

Bone marrow cell transplantation safely improves heart function after myocardial infarction. This therapy promotes heart healing through cell regeneration and new blood vessel growth, reducing heart failure risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of pre-existing CIED on mid-term mortality in patients undergoing TAVR.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Biographical Feature: Raymond M. Welsh, Jr. (1945-2024)-a life in viral immunology, immune regulation, and scientific mentorship.

Journal of virology·2026
Same author

Prognostic impact of iliofemoral access-site calcification volume on outcomes after transcatheter aortic valve implantation.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Development of a Novel Holistic Assessment Strategy of TAVI-Induced Flow Restoration via Dimensionality Reduction Techniques.

Cardiovascular engineering and technology·2026
Same author

Impact of Virtual Reality on Transcatheter Aortic Valve Implantation: A Prospective Randomized Controlled Trial.

Circulation. Cardiovascular imaging·2026
Same author

Heart Transplantation on Temporary Mechanical Circulatory Support: A Single-Center Study (2010-2024).

The Thoracic and cardiovascular surgeon·2026

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Left ventricular remodeling post-myocardial infarction (MI) is a primary driver of heart failure and mortality.
  • Bone marrow-derived cells show potential for aiding myocardial repair after MI.
  • Current therapeutic strategies for MI often fall short in fully restoring cardiac function.

Purpose of the Study:

  • To evaluate the safety and efficacy of autologous mononuclear bone marrow cell transplantation in patients with MI.
  • To assess the impact of this cell therapy on cardiac function, myocardial perfusion, and metabolism.
  • To explore the underlying mechanisms of therapeutic benefit, including myocardial regeneration and neovascularization.

Main Methods:

  • Selective intracoronary transplantation of autologous, mononuclear bone marrow cells.

Related Experiment Videos

  • Clinical assessment of heart function, myocardial perfusion, and metabolic parameters post-transplantation.
  • Evaluation of potential cell-mediated mechanisms contributing to cardiac repair.

    • Main Results:

    • Intracoronary transplantation of autologous bone marrow cells was found to be safe in the clinical setting.
    • The procedure demonstrated apparent effectiveness in improving heart function, myocardial perfusion, and metabolism.
    • Therapeutic benefits are potentially linked to bone marrow cell-induced myocardial regeneration and neovascularization.

    Conclusions:

    • Autologous mononuclear bone marrow cell transplantation is a safe and potentially effective therapy for patients following myocardial infarction.
    • This cell-based approach may offer a novel strategy to combat infarct-related heart failure by promoting cardiac repair.
    • Further research is warranted to fully elucidate the regenerative and angiogenic potential of bone marrow cells in cardiac healing.